These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1699622

  • 1. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
    Cairo MS, Plunkett JM, Mauss D, Van de ven C.
    Blood; 1990 Nov 01; 76(9):1788-94. PubMed ID: 1699622
    [Abstract] [Full Text] [Related]

  • 2. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.
    Cairo MS, Plunkett JM, Nguyen A, van de Ven C.
    Blood; 1992 Jul 01; 80(1):96-101. PubMed ID: 1377057
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS, Mauss D, Kommareddy S, Norris K, van de Ven C, Modanlou H.
    Pediatr Res; 1990 Jun 01; 27(6):612-6. PubMed ID: 1694023
    [Abstract] [Full Text] [Related]

  • 4. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun 01; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 5. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS, Mauss D, Plunkett JM, Gillis S, van de Ven C.
    Pediatr Res; 1991 May 01; 29(5):504-9. PubMed ID: 1896256
    [Abstract] [Full Text] [Related]

  • 6. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS, Plunkett JM, Schendel P, van de Ven C.
    Exp Hematol; 1994 Oct 01; 22(11):1118-23. PubMed ID: 7523164
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
    Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS.
    Blood; 1994 Sep 01; 84(5):1427-33. PubMed ID: 7520770
    [Abstract] [Full Text] [Related]

  • 8. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.
    Cairo MS, van de Ven C, Mauss D, Kommareddy S, Norris K, Sheikh K, Modanlou H.
    Biol Neonate; 1991 Sep 01; 59(1):13-21. PubMed ID: 1707685
    [Abstract] [Full Text] [Related]

  • 9. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection.
    Novales JS, Salva AM, Modanlou HD, Kaplan DL, del Castillo J, Andersen J, Medlock ES.
    Blood; 1993 Feb 15; 81(4):923-7. PubMed ID: 7679008
    [Abstract] [Full Text] [Related]

  • 10. Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor.
    Cairo MS, Plunkett JM, Nguyen A, Schendel P, van de Ven C.
    Pediatr Res; 1993 Jul 15; 34(1):56-61. PubMed ID: 7689197
    [Abstract] [Full Text] [Related]

  • 11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 12. Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.
    Cairo MS, Plunkett JM, Nguyen A, Clark S, van de Ven C.
    Pediatr Res; 1991 Dec 15; 30(6):554-9. PubMed ID: 1725208
    [Abstract] [Full Text] [Related]

  • 13. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.
    Exp Hematol; 1991 Sep 15; 19(8):759-67. PubMed ID: 1714401
    [Abstract] [Full Text] [Related]

  • 14. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR, del Castillo J, McNiece I, Watson L, Yin SM, Andresen J.
    Am J Pathol; 1990 Aug 15; 137(2):369-76. PubMed ID: 1696784
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis.
    Medlock ES, Kaplan DL, Cecchini M, Ulich TR, del Castillo J, Andresen J.
    Blood; 1993 Feb 15; 81(4):916-22. PubMed ID: 7679007
    [Abstract] [Full Text] [Related]

  • 16. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P, La Gamma EF.
    Pediatrics; 1997 Jul 15; 100(1):E6. PubMed ID: 9200380
    [Abstract] [Full Text] [Related]

  • 17. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR, Davies EG, Gibson FM, Gordon-Smith EC.
    Pediatr Res; 1995 May 15; 37(5):630-3. PubMed ID: 7541523
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G.
    Blood; 1997 Oct 01; 90(7):2565-73. PubMed ID: 9326222
    [Abstract] [Full Text] [Related]

  • 19. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM, Jhung JW, Keith JC, Goldman SJ, Palardy JE, Parejo NA.
    Blood; 1999 May 15; 93(10):3467-72. PubMed ID: 10233899
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human granulocyte colony-stimulating factor accelerates regeneration after T-2 toxin-induced hemopoietic injury and lessens lethality in mice.
    Ohtani K, Nanya T, Aoyama Y, Matsunami S, Sekijima M, Kawamura O, Ohtsubo K, Ueno Y.
    J Toxicol Sci; 1993 Aug 15; 18(3):155-66. PubMed ID: 7504113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.